- Nachrichtendetail
-
13.05.2024 12:50:41 - dpa-AFX: *MERCK ANNOUNCES DISCONTINUATION OF VIBOSTOLIMAB AND PEMBROLIZUMAB COFORMULATION ARM OF PHASE 3 KEYVIBE-010 TRIAL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
MERCK CO. DL-,01 | A0YD8Q | Xetra | 122,000 | 10.06.24 15:35:10 | +0,600 | +0,49% | 121,600 | 122,200 | 120,400 | 121,400 |
